6.1 Brevetto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4809
NA - Nord America 4068
AS - Asia 838
Continente sconosciuto - Info sul continente non disponibili 23
Totale 9738
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4059
IT - Italia 1280
SE - Svezia 1185
IE - Irlanda 875
TR - Turchia 436
DE - Germania 423
UA - Ucraina 393
GB - Regno Unito 240
CN - Cina 223
VN - Vietnam 156
FI - Finlandia 118
RU - Federazione Russa 103
AT - Austria 77
BE - Belgio 61
AL - Albania 23
EU - Europa 23
SG - Singapore 15
FR - Francia 11
CA - Canada 9
NL - Olanda 9
CH - Svizzera 5
IN - India 4
HK - Hong Kong 2
HU - Ungheria 2
ES - Italia 1
IM - Isola di Man 1
IR - Iran 1
ME - Montenegro 1
RO - Romania 1
TH - Thailandia 1
Totale 9738
Salva come PNG Salva come JPEG
Città #
Pisa 943
Jacksonville 913
Dublin 875
Chandler 804
Izmir 435
Wilmington 393
Ann Arbor 379
Düsseldorf 194
Millbury 187
Boston 179
Dong Ket 156
Ashburn 143
San Mateo 123
Mestre 112
Woodbridge 99
Dearborn 89
Beijing 85
Seattle 85
Bremen 82
Lawrence 73
Vienna 71
Scuola 67
Princeton 61
Brussels 60
Saint Petersburg 46
Nanjing 22
Padova 21
Boardman 20
Hefei 20
Kunming 19
Milan 15
Norwalk 15
Andover 14
Fairfield 13
Bientina 11
Cambridge 11
Guangzhou 11
Jinan 9
San Diego 8
Nanchang 7
Verona 7
Graz 6
Serra 6
Toronto 6
Centrale 5
Florence 5
Houston 5
Auburn Hills 4
Berlin 4
Chengdu 4
Jiaxing 4
Lausanne 4
Rome 4
Shaoxing 4
Shenyang 4
Zhengzhou 4
Brescia 3
Chantilly 3
Fuzhou 3
Leawood 3
Quzhou 3
Trumbull 3
Budapest 2
Castelfranco Veneto 2
Grevenbroich 2
Hanover 2
London 2
Los Angeles 2
Mumbai 2
Nanning 2
Redmond 2
Savona 2
Shanghai 2
Simi Valley 2
Taranto 2
Wenzhou 2
Amsterdam 1
Antwerpen 1
Arnsberg 1
Bangalore 1
Bari 1
Changsha 1
Chaoyang 1
Chicago 1
Chongqing 1
Dallas 1
Douglas 1
Genova 1
Guiyang 1
Harbin 1
Hebei 1
Henderson 1
Jinhua 1
Kocaeli 1
Krimpen Aan Den Ijssel 1
Laurel 1
Messina 1
Miami 1
Modena 1
Mola Di Bari 1
Totale 7016
Salva come PNG Salva come JPEG
Nome #
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 166
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 146
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 146
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 143
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 131
Composti particolarmente catalizzatori di poliuretani 128
Vettore per il rilascio di un agente attivo, fotoscindibile per irraggiamento nel visibile 125
Method and device for measuring position and mass 121
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 121
Compositions able to prevent neurodegenerative processes and methods of assaying the same 120
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 116
Non-human transgenic animals for the study of neurodegenerative syndromes 112
Non-human transgenic animals for the study of neurodegenerative syndromes 110
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 107
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 107
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 107
Vettore per il rilascio di un agente attivo, fotoscindibile per irraggiamento nel visibile 103
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 103
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 102
Muteins of hNGF, therapeutic uses and pharmaceutical compositions 101
Transgenic mice for the study of neurodegenerative syndromes 100
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 94
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 94
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 94
Method for the humanization of antibodies and humanized antibodies thereby obtained 93
Bucket brigade address decoding architecture for classical and quantum random access memories 92
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 92
Method for the humanization of antibodies and humanized antibodies thereby obtained 89
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 88
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 88
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 87
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 87
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 87
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 85
Intracellular selection 85
Method for the potentiation of opioid analgesics effects on pain 84
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 83
INTRACELLULAR ANTIBODIES 82
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 82
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 82
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 81
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 81
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 81
Selection of intracellular immunoglobulins 80
Laser circolari a semiconduttore con reticoli per emissione verticale 80
Method of identifying a consensus sequence for intracellular antibodies 79
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 78
Non-human transgenic animals for the study of neurodegenerative syndromes 78
Method for the humanization of antibodies and humanized antibodies thereby obtained. 78
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 78
INTRACELLULAR ANTIBODIES 78
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 77
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 76
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 76
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 76
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 76
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 76
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 76
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 75
Method for the humanization of antibodies and humanized antibodies thereby obtained. 75
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 75
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 75
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 74
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 74
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 74
Intracellular selection 74
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 74
Method for the humanization of antibodies and humanized antibodies thereby obtained. 73
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 73
Intracellular selection 73
Humanized anti-NGF antibodies 72
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 72
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 72
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 72
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 72
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 71
Novel analgesic treatment with prolonged effect 71
Selection of intracellular immunoglobulins 71
Selection of intracellular immunoglobulins 71
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 71
Humanized anti-NGF antibodies 70
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 70
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 70
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 70
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 70
Method for the potentiation of opioid analgesics effects on pain 69
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 69
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 69
Humanized anti-NGF antibodies 68
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 68
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 67
Selection of intracellular immunoglobulins 67
Novel analgesic treatment with prolonged effect 67
METHOD OF IDENTIFYING A CONSENSUS SEQUENCE FOR INTRACELLULAR ANTIBODIES 67
Method for the humanization of antibodies and humanized antibodies thereby obtained. 66
Method for the humanization of antibodies and humanized antibodies thereby obtained. 66
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 66
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 65
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 65
Method for the humanization of antibodies and humanized antibodies thereby obtained 64
Totale 8545
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018193 0000 00 00 78613123
2018/2019705 7562 1141 838 655436
2019/20201218 146114281 14177 30545 1406413423
2020/20211836 138838010 122159 82131 14528295284
2021/2022971 126324129 155 1073 545919454
2022/20233696 254151147248 165409 211102 1199000
Totale 9852